Compare NUVB & AERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | AERO |
|---|---|---|
| Founded | 2018 | 1934 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | N/A | N/A |
| Metric | NUVB | AERO |
|---|---|---|
| Price | $5.89 | $18.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $11.44 | ★ $30.83 |
| AVG Volume (30 Days) | ★ 4.0M | 363.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $659.84 | $7.14 |
| Revenue Next Year | $180.43 | $4.82 |
| P/E Ratio | ★ N/A | $7.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $16.00 |
| 52 Week High | $9.75 | $23.05 |
| Indicator | NUVB | AERO |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 44.55 |
| Support Level | $5.12 | $18.91 |
| Resistance Level | $6.22 | $19.66 |
| Average True Range (ATR) | 0.33 | 1.09 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 77.97 | 37.99 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.